OfloxacinAza CompoundsQuinolinesFluoroquinolonesLevofloxacinAnti-Infective AgentsMicrobial Sensitivity TestsCiprofloxacinAnti-Bacterial AgentsQuinolonesNaphthyridinesDNA GyraseEnoxacinNorfloxacinDrug Resistance, Bacterial4-QuinolonesAntitubercular AgentsDrug Resistance, MicrobialRifampinStreptococcus pneumoniaeDNA Topoisomerase IVEye Infections, BacterialPefloxacinOxazinesColony Count, MicrobialAntibiotics, AntitubercularArea Under CurveAzithromycinGram-Positive BacteriaStaphylococcus aureusAdministration, OralMycobacterium tuberculosisAmoxicillin-Potassium Clavulanate CombinationEthambutolBacteria, AnaerobicBronchitis, ChronicDrug Therapy, CombinationGram-Negative BacteriaLeprostatic AgentsBacteroides InfectionsBacteroides fragilisSerum Bactericidal TestDNA Topoisomerases, Type IIBacterial InfectionsHalf-LifeBacteria, AerobicTuberculosis, Multidrug-ResistantMycoplasma hominisErythromycinDrug Resistance, Multiple, BacterialCorneal UlcerIsoniazidClofazimineTopoisomerase II InhibitorsCeftriaxoneDoxycyclineKeratitisBiological AvailabilityEndophthalmitisNalidixic AcidIntraabdominal InfectionsPneumococcal InfectionsPiperacillinOxazolidinonesClindamycinAcetamidesChromatography, High Pressure LiquidTrimethoprim-Sulfamethoxazole CombinationBacteriaEthionamideErysipelasClarithromycinPeriodontal AbscessStomach RuptureStenotrophomonas maltophiliaInjections, IntravenousBlepharitisCefuroximeCentral Nervous System Bacterial InfectionsClinical Trials, Phase IV as TopicDouble-Blind MethodStaphylococcal InfectionsTuberculosis, PulmonaryMacrolidesMycobacterium fortuitumExtensively Drug-Resistant TuberculosisHepatic InsufficiencyDrug Administration ScheduleMinocyclineGram-Positive CocciOphthalmic SolutionsPenicillinsDiarylquinolinesPenicillin ResistancePyrazinamideTyphoid FeverLeg BonesTreatment OutcomeMutationDrug Interactions